Home › Funds › Trails Edge Capital Partners, LP › CAMP

Trails Edge Capital Partners, LP position in CAMP

CAMP4 THERAPEUTICS CORP · Health Care

Trails Edge Capital Partners, LP reported holding 3,625,576 shares of CAMP (CAMP4 THERAPEUTICS CORP) in its Q3 2026 13F filing — a position valued at US$14.6M, representing 2.10% of its reported portfolio and ranking #21 among its reported holdings. Trails Edge Capital Partners, LP has disclosed CAMP holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)3.63M sh
Reported value held$14.65M
Portfolio Weight2.10%
First reportedQ4 2025
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Trails Edge Capital Partners, LP's CAMP position evolved

Trails Edge Capital Partners, LP first disclosed a stake in CAMP in Q4 2025 at 1,983,986 shares (US$12.2M). The position peaked in Q3 2026 at 3,625,576 shares, worth US$14.6M. Across 4 filings, Trails Edge Capital Partners, LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 3,625,576 shares valued at US$14.6M — an increase of 1,692,639 shares quarter over quarter.. Notable position changes include a 88% increase in Q3 2026 (shares fell 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.98M $12.16M New
Q1 2026 1.94M $8.55M Reduce
Q2 2026 1.93M $8.45M Hold
Q3 2026 3.63M $14.65M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CAMP and 13F data

CAMP (CAMP4 THERAPEUTICS CORP) is a Health Care company. 39 other funds we track also report a position in CAMP — the largest reported positions include 5AM Venture Management, LLC (US$25.6M), Vivo Capital, LLC (US$22.6M), Stonepine Capital Management, LLC (US$11.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CAMP

All CAMP fund holders →

FAQ

How long has Trails Edge Capital Partners, LP held CAMP?

Trails Edge Capital Partners, LP has disclosed CAMP holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Trails Edge Capital Partners, LP's current position in CAMP?

As of Q3 2026, Trails Edge Capital Partners, LP holds 3.63M shares of CAMP (CAMP4 THERAPEUTICS CORP), valued at $14.65M, representing 2.10% of its reported portfolio and ranking #21.

Has Trails Edge Capital Partners, LP been buying or selling CAMP?

In the latest 13F filing (Q3 2026), Trails Edge Capital Partners, LP increased its position in CAMP. The position peaked in Q3 2026 at 3.63M shares.

Which other funds hold CAMP?

Other major institutional holders of CAMP include 5AM Venture Management, LLC, Vivo Capital, LLC, Stonepine Capital Management, LLC, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.